BRAF-targeted therapy alters the functions of intratumoral CD4<sup>+</sup> T cells to inhibit melanoma progression.
Détails
ID Serval
serval:BIB_7C3678EE2D42
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Lettre (letter): communication adressée à l'éditeur.
Collection
Publications
Institution
Titre
BRAF-targeted therapy alters the functions of intratumoral CD4<sup>+</sup> T cells to inhibit melanoma progression.
Périodique
Oncoimmunology
ISSN
2162-4011 (Print)
ISSN-L
2162-4011
Statut éditorial
Publié
Date de publication
18/06/2014
Peer-reviewed
Oui
Volume
3
Pages
e29126
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Publication Status: epublish
Résumé
The establishment of an immunosuppressive tumor microenvironment is a hallmark feature driving cancer cell evasion of immunosurveillance. In a murine melanoma model, we recently demonstrated that decreased intratumoral CD4 <sup>+</sup> T-cell expression of CD40L and interferon γ (IFNγ) is critical to maintain this immunosuppressive microenvironment. Altered effector functions of tumor-associated CD4 <sup>+</sup> T cells is essential for B-Raf <sup>V600E</sup> inhibitor-mediated restoration of antitumor immunity.
Mots-clé
BRAF, CD40L, IFNγ, T cell, melanoma
Pubmed
Web of science
Open Access
Oui
Création de la notice
05/04/2019 15:50
Dernière modification de la notice
20/08/2019 14:37